Zhu, A. X., Ancukiewicz, M., Supko, J. G., Sahani, D. V., Blaszkowsky, L. S., Meyerhardt, J. A., . . . Duda, D. G. (2013). Efficacy, safety, pharmacokinetics and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: A phase II study.
Chicago Style CitationZhu, Andrew X., et al. Efficacy, Safety, Pharmacokinetics and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study. 2013.
Cita MLAZhu, Andrew X., et al. Efficacy, Safety, Pharmacokinetics and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study. 2013.
Atenció: Aquestes cites poden no estar 100% correctes.